Cargando…
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060130/ https://www.ncbi.nlm.nih.gov/pubmed/32076273 http://dx.doi.org/10.1038/s41586-020-2015-4 |
_version_ | 1783504165866045440 |
---|---|
author | Moral, John Alec Leung, Joanne Rojas, Luis A. Ruan, Jennifer Zhao, Julia Sethna, Zachary Ramnarain, Anita Gasmi, Billel Gururajan, Murali Redmond, David Askan, Gokce Bhanot, Umesh Elyada, Ela Park, Youngkyu Tuveson, David A. Gönen, Mithat Leach, Steven D. Wolchok, Jedd D. DeMatteo, Ronald P. Merghoub, Taha Balachandran, Vinod P. |
author_facet | Moral, John Alec Leung, Joanne Rojas, Luis A. Ruan, Jennifer Zhao, Julia Sethna, Zachary Ramnarain, Anita Gasmi, Billel Gururajan, Murali Redmond, David Askan, Gokce Bhanot, Umesh Elyada, Ela Park, Youngkyu Tuveson, David A. Gönen, Mithat Leach, Steven D. Wolchok, Jedd D. DeMatteo, Ronald P. Merghoub, Taha Balachandran, Vinod P. |
author_sort | Moral, John Alec |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7060130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-70601302020-08-19 ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity Moral, John Alec Leung, Joanne Rojas, Luis A. Ruan, Jennifer Zhao, Julia Sethna, Zachary Ramnarain, Anita Gasmi, Billel Gururajan, Murali Redmond, David Askan, Gokce Bhanot, Umesh Elyada, Ela Park, Youngkyu Tuveson, David A. Gönen, Mithat Leach, Steven D. Wolchok, Jedd D. DeMatteo, Ronald P. Merghoub, Taha Balachandran, Vinod P. Nature Article 2020-02-19 2020-03 /pmc/articles/PMC7060130/ /pubmed/32076273 http://dx.doi.org/10.1038/s41586-020-2015-4 Text en Reprints and permissions information is available at http://www.nature.com/reprints. Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Moral, John Alec Leung, Joanne Rojas, Luis A. Ruan, Jennifer Zhao, Julia Sethna, Zachary Ramnarain, Anita Gasmi, Billel Gururajan, Murali Redmond, David Askan, Gokce Bhanot, Umesh Elyada, Ela Park, Youngkyu Tuveson, David A. Gönen, Mithat Leach, Steven D. Wolchok, Jedd D. DeMatteo, Ronald P. Merghoub, Taha Balachandran, Vinod P. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
title | ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
title_full | ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
title_fullStr | ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
title_full_unstemmed | ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
title_short | ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
title_sort | ilc2s amplify pd-1 blockade by activating tissue-specific cancer immunity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060130/ https://www.ncbi.nlm.nih.gov/pubmed/32076273 http://dx.doi.org/10.1038/s41586-020-2015-4 |
work_keys_str_mv | AT moraljohnalec ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT leungjoanne ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT rojasluisa ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT ruanjennifer ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT zhaojulia ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT sethnazachary ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT ramnarainanita ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT gasmibillel ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT gururajanmurali ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT redmonddavid ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT askangokce ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT bhanotumesh ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT elyadaela ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT parkyoungkyu ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT tuvesondavida ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT gonenmithat ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT leachstevend ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT wolchokjeddd ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT dematteoronaldp ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT merghoubtaha ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity AT balachandranvinodp ilc2samplifypd1blockadebyactivatingtissuespecificcancerimmunity |